These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 12856144)
1. Usefulness of Tc-99m ECD brain SPECT to evaluate the effects of methylprednisolone pulse therapy in lupus erythematosus with brain involvement: a preliminary report. Liu FY; Huang WS; Kao CH; Yen RF; Wang JJ; Ho ST Rheumatol Int; 2003 Jul; 23(4):182-5. PubMed ID: 12856144 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effects of methylprednisolone pulse therapy in patients with systemic lupus erythematosus with brain involvement by Tc-99m HMPAO brain SPECT. Sun SS; Huang WS; Chen JJ; Chang CP; Kao CH; Wang JJ Eur Radiol; 2004 Jul; 14(7):1311-5. PubMed ID: 14663624 [TBL] [Abstract][Full Text] [Related]
3. Abnormal regional cerebral blood flow found by technetium-99m ethyl cysteinate dimer brain single photon emission computed tomography in systemic lupus erythematosus patients with normal brain MRI findings. Chen JJ; Yen RF; Kao A; Lin CC; Lee CC Clin Rheumatol; 2002 Nov; 21(6):516-9. PubMed ID: 12447638 [TBL] [Abstract][Full Text] [Related]
4. Objective evidence of abnormal regional cerebral blood flow in patients with systemic lupus erythematosus on Tc-99m ECD brain SPECT. Huang WS; Chiu PY; Tsai CH; Kao A; Lee CC Rheumatol Int; 2002 Sep; 22(5):178-81. PubMed ID: 12215861 [TBL] [Abstract][Full Text] [Related]
5. Abnormal regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with normal magnetic resonance imaging findings. A preliminary report. Chen JJ; Shiau YC; Wang JJ; Ho ST; Kao A Scand J Rheumatol; 2002; 31(2):89-93. PubMed ID: 12109653 [TBL] [Abstract][Full Text] [Related]
6. Detecting abnormal regional cerebral blood flow in patients with primary Sjögren's syndrome by technetium-99m ethyl cysteinate dimer single photon emission computed tomography of the brain--a preliminary report. Huang WS; Chiu PY; Kao A; Tsai CH; Lee CC Rheumatol Int; 2003 Jul; 23(4):174-7. PubMed ID: 12856142 [TBL] [Abstract][Full Text] [Related]
7. Abnormal regional cerebral blood flow on 99mTc ECD brain SPECT in patients with primary Sjögren's syndrome and normal findings on brain magnetic resonance imaging. Chang CP; Shiau YC; Wang JJ; Ho ST; Kao A Ann Rheum Dis; 2002 Sep; 61(9):774-8. PubMed ID: 12176800 [TBL] [Abstract][Full Text] [Related]
8. Voxel-based morphometry of brain SPECT can detect the presence of active central nervous system involvement in systemic lupus erythematosus. Appenzeller S; Amorim BJ; Ramos CD; Rio PA; de C Etchebehere EC; Camargo EE; Cendes F; Costallat LT Rheumatology (Oxford); 2007 Mar; 46(3):467-72. PubMed ID: 16901949 [TBL] [Abstract][Full Text] [Related]
9. Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report. Sun SS; Liu FY; Tsai JJ; Yen RF; Kao CH; Huang WS Rheumatol Int; 2003 Nov; 23(6):301-4. PubMed ID: 12684837 [TBL] [Abstract][Full Text] [Related]
10. Database of normal human cerebral blood flow measured by SPECT: I. Comparison between I-123-IMP, Tc-99m-HMPAO, and Tc-99m-ECD as referred with O-15 labeled water PET and voxel-based morphometry. Ito H; Inoue K; Goto R; Kinomura S; Taki Y; Okada K; Sato K; Sato T; Kanno I; Fukuda H Ann Nucl Med; 2006 Feb; 20(2):131-8. PubMed ID: 16615422 [TBL] [Abstract][Full Text] [Related]
11. Early and delayed Tc-99m ECD brain SPECT in SLE patients with CNS involvement. Kikukawa K; Toyama H; Katayama M; Nishimura T; Ejiri K; Minami K; Matsumura K; Miyama H; Emoto Y; Maeda H; Senda K; Takeuchi A; Oshima H; Yoshida S; Torikai K; Koga S Ann Nucl Med; 2000 Feb; 14(1):25-32. PubMed ID: 10770577 [TBL] [Abstract][Full Text] [Related]
12. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults. Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088 [TBL] [Abstract][Full Text] [Related]
13. Decreased cerebral blood flow in neuro-Behçet's syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging--a preliminary report. Huang WS; Chiu PY; Kao A; Tsai CH; Lee CC J Neuroimaging; 2002 Oct; 12(4):355-9. PubMed ID: 12380483 [TBL] [Abstract][Full Text] [Related]
14. Cerebral hypoperfusion detected by SPECT in patients with systemic lupus erythematosus is related to clinical activity and cumulative tissue damage. López-Longo FJ; Carol N; Almoguera MI; Olazarán J; Alonso-Farto JC; Ortega A; Monteagudo I; González CM; Carreño L Lupus; 2003; 12(11):813-9. PubMed ID: 14667096 [TBL] [Abstract][Full Text] [Related]
15. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings. Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015 [TBL] [Abstract][Full Text] [Related]
16. [Arterial clearance and cerebral uptake of Tc-99m ECD in patients with cerebrovascular disease compared with PET]. Shishido F; Uemura K; Murakami M; Inugami A; Ogawa T; Higano S; Fujita H; Shimosegawa E; Kanno I; Aizawa Y Kaku Igaku; 1992 Jan; 29(1):27-35. PubMed ID: 1578819 [TBL] [Abstract][Full Text] [Related]
17. [Nuclear medicine for general radiologists: clinical application of brain SPECT]. Kuwabara Y Nihon Igaku Hoshasen Gakkai Zasshi; 2000 Oct; 60(12):671-7. PubMed ID: 11155695 [TBL] [Abstract][Full Text] [Related]
18. SPECT imaging of normal subjects with technetium-99m-HMPAO and technetium-99m-ECD. Koyama M; Kawashima R; Ito H; Ono S; Sato K; Goto R; Kinomura S; Yoshioka S; Sato T; Fukuda H J Nucl Med; 1997 Apr; 38(4):587-92. PubMed ID: 9098207 [TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-HMPAO, technetium-99m-ECD and iodine-123-IMP cerebral blood flow measurements with pharmacological interventions in primates. Dormehl IC; Oliver DW; Langen KJ; Hugo N; Croft SA J Nucl Med; 1997 Dec; 38(12):1897-901. PubMed ID: 9430465 [TBL] [Abstract][Full Text] [Related]
20. Persistent brain damage in reversible cerebral vasoconstriction syndrome on Kunitake K; Ogura A; Iwata-Hatanaka M; Inagaki R; Furukawa S; Suzuki J; Nakai N; Nishida S; Katsuno M; Ito Y J Neurol Sci; 2022 Nov; 442():120441. PubMed ID: 36209569 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]